BELLUS Health Inc. BLU
Set alert
14.75 0.00 0.00%
As of Jun 28, 3:59 PM ET
14.74 Day range 14.75
52-week range unavailable
- Open
- 14.74
- Prev close
- 14.75
- Mkt cap
- 1.87B
- Vol
- 2.84M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.74
- High
- 14.75
- Forward P/E
- -12.39
- Beta
- -0.28
- Short ratio
- 2.61
- Inst. own
- 90.41%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2023
- 50-d avg
- 14.59
- 200-d avg
- 10.22
- 1y target
- 16.05
3M chart
Events in this range
- Apr 18, 2023Downgrade: Evercore ISI Group · Outperform → In-Line
- Apr 19, 2023Downgrade: Jefferies · Buy → Hold
- Apr 19, 2023Downgrade: RBC Capital · Outperform → Sector Perform
- May 12, 2023Earnings: —; estimate -0.2; surprise —%
- May 15, 2023Rating: RBC Capital · Sector Perform → Sector Perform
Signals (6)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | May 8, 2023 | 3 years ago |
| SMA: Bullish | Apr 18, 2023 | 3 years ago |
| SMA: Bullish | Apr 18, 2023 | 3 years ago |
| RSI: Overbought | Apr 18, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 13, 2023 | 3 years ago |
| RSI: Oversold | Apr 5, 2023 | 3 years ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 16.05 +8.9% upside
Now 14.75
- Target (low)
- 14.75
- Target (mean)
- 16.05
- Target (high)
- 20.00
Ratings (-1m) 6 2 buy · 4 hold · 0 sell
- Strong buy0
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 6
- 2 months ago 7
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.24 | -0.24 – -0.24 | -0.18 | -33.3% | 0 | 0.0% | 1 |
| Next quarter | -0.26 | -0.26 – -0.26 | -0.20 | -30.0% | 0 | 0.0% | 1 |
| Current year | -0.88 | -0.88 – -0.88 | -0.66 | -33.3% | 0 | 0.0% | 1 |
| Next year | -1.19 | -1.19 – -1.19 | -0.88 | -35.2% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 15, 2023 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Apr 19, 2023 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Apr 19, 2023 | Jefferies | Downgrade | Buy | Hold |
| Apr 18, 2023 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Mar 22, 2023 | RBC Capital | Reiterated | — | Outperform |
| Mar 22, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Sep 30, 2022 | RBC Capital | Maintained | — | Outperform |
| Sep 23, 2022 | Jefferies | Maintained | — | Buy |
| Aug 11, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 13, 2022 | RBC Capital | Maintained | — | Outperform |
| Feb 24, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 13, 2021 | Evercore ISI Group | Maintained | — | Outperform |
| Dec 7, 2021 | RBC Capital | Maintained | — | Outperform |
| Oct 18, 2021 | RBC Capital | Maintained | — | Outperform |
| Sep 14, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 29, 2021 | BTIG | Initiated | — | Buy |
| Jan 29, 2021 | RBC Capital | Initiated | — | Outperform |
| Nov 25, 2020 | Jefferies | Initiated | — | Buy |
| Nov 18, 2020 | Evercore ISI Group | Initiated | — | Outperform |
| Aug 14, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 7, 2020 | Baird | Maintained | — | Outperform |
| Jul 7, 2020 | Guggenheim | Downgrade | Buy | Neutral |
| Jun 26, 2020 | HC Wainwright & Co. | Initiated | — | Buy |